CoChat

Selenium supplementation and insulin resistance in a randomized, clinical trial

Open access

The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.

Abstract

Objective: While controversial, observational and randomized clinical trial data implicate the micronutrient selenium (Se) in the development of type 2 diabetes (T2D). The aim of this study was to test the hypothesis that Se supplementation adversely affects pancreatic β-cell function and insulin sensitivity. Research design and methods: In a subset of 400 individuals participating in a randomized, placebo-controlled trial of Se at 200 µg/day for colorectal adenomatous polyps, fasting plasma glucose and insulin were measured before randomization and within 6 months of completing intervention. Change in the homeostasis model assessment-β cell function (HOMA2-%β) and insulin sensitivity (HOMA2-%S) were compared between arms. A subgroup of 175 (79 Se and 96 placebo) participants underwent a modified oral glucose tolerance test (mOGTT) at the end of intervention and change in glucose values was assessed. Results: No statistically significant differences were observed for changes in HOMA2-%β or HOMA2-%S between those who received Se compared with placebo. After a mean of 2.9 years on study, mean HOMA2-%β values were 3.1±24.0 and 3.1±29.8 for the Se and placebo groups, respectively (p=0.99). For HOMA2-%S, the values were −0.5±223.2 and 80.9±1530.9 for the Se and placebo groups, respectively (p=1.00). Stratification by sex or age did not reveal any statistically significant effects on insulin sensitivity by treatment group. For mOGTT, mean baseline fasting blood glucose concentrations were significantly higher among participants in the placebo group compared with the Se group (96.6±14.6 and 92.3±12.0, respectively; p=0.04), a trend which remained through the 20 min assessment. Conclusions: These findings do not support a significant adverse effect of daily Se supplementation with 200 µg/day of selenized yeast on β-cell function or insulin sensitivity as an explanation for previously reported associations between Se and T2D. Further clarification of longer term effects of Se is needed. Clinical trial registry: NIH Clinical Trials.gov number NCT00078897.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2018-000613

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. 10.1001/jama.1996.03540240035027 · DOI · Paper page

Cited by

See all 41

Metadata

Authors
Jacobs, E. T., Lance, P., Mandarino, L. J., Ellis, N. A., Chow, H.-H. S., Foote, J., Martinez, J. A., Hsu, C.-H. P., Batai, K., Saboda, K., & Thompson, P. A.
Affiliations
  • University of Arizona (US)
  • University of Arizona Cancer Center (US)
  • Stony Brook University (US)
Corresponding author
Jacobs, Elizabeth Theresa
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2019-02
Volume
7
Issue
1
Pages
e000613
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2912097322
Cited by
41
References
28
Citations by year
2026: 4 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 8 · 2019: 2
FWCI
4.57
Type
journal article
Language
en
Open access
Locations
  • BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Cancer Institute (P01CA041108, P30CA023074, R01CA151708)
  • National Institutes of Health (R01DK047396)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Selenium in Biological Systems
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Physical Sciences › Chemistry › Organic Chemistry › Organoselenium and organotellurium chemistry
Keywords
selenium supplementation, insulin resistance, insulin sensitivity, beta-cell function, type 2 diabetes, selenium yeast, colorectal adenoma, HOMA2, fasting blood glucose
MeSH terms
Adenoma, Adult, Aged, Aged, 80 and over, Female, Humans, Insulin Resistance, Male, Middle Aged, Polyps, Selenium, Colorectal Neoplasms, Randomized Controlled Trials as Topic, Dietary Supplements, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selenium supplementation and insulin resistance in a randomized, clinical trial. https://app.cochat.ai/papers/10.1136/bmjdrc-2018-000613
The paper
Jacobs, E. T., Lance, P., Mandarino, L. J., Ellis, N. A., Chow, H.-H. S., Foote, J., Martinez, J. A., Hsu, C.-H. P., Batai, K., Saboda, K., & Thompson, P. A. (2019). Selenium supplementation and insulin resistance in a randomized, clinical trial. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2018-000613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.